CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 273 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $541,665 | -25.0% | 5,371 | +1.1% | 0.17% | -26.6% |
| Q2 2023 | $722,255 | +10.1% | 5,315 | -15.8% | 0.23% | +11.2% |
| Q1 2023 | $655,772 | +63.6% | 6,314 | +39.6% | 0.21% | +52.6% |
| Q4 2022 | $400,919 | +11.1% | 4,523 | +0.4% | 0.14% | -5.6% |
| Q3 2022 | $361,000 | -16.2% | 4,505 | 0.0% | 0.14% | -8.3% |
| Q2 2022 | $431,000 | -36.1% | 4,505 | -0.8% | 0.16% | -14.8% |
| Q1 2022 | $675,000 | +7.3% | 4,542 | +2.4% | 0.18% | +8.9% |
| Q4 2021 | $629,000 | +8.3% | 4,435 | -0.1% | 0.17% | -1.2% |
| Q3 2021 | $581,000 | -3.8% | 4,441 | +1.1% | 0.17% | -3.4% |
| Q2 2021 | $604,000 | +7.7% | 4,393 | +2.3% | 0.18% | -8.8% |
| Q1 2021 | $561,000 | +23.3% | 4,294 | +5.7% | 0.19% | +12.9% |
| Q4 2020 | $455,000 | +93.6% | 4,061 | +36.0% | 0.17% | +55.5% |
| Q3 2020 | $235,000 | +5775.0% | 2,985 | +5136.8% | 0.11% | +5400.0% |
| Q1 2018 | $4,000 | – | 57 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
| Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
| Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
| Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
| EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
| MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
| Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
| OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
| Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |